In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally ...
ProQR Therapeutics N.V. (NASDAQ:PRQR) earns a spot in our list of the top 10 stocks under $5 that could triple. As of March 19, 2026, analysts remain confident in ProQR Therapeutics N.V. (NASDAQ:PRQR) ...
DelveInsight’s, “Hepatic Tumor Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and ...
ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies ...
Sarepta (SRPT) stock rises on positive Phase 1/2 siRNA trial data showing muscle delivery, biomarker activity, and safety in ...
Existing bacteria and archaea still our universal common ancestor’s ribosomal hibernation defense mechanism when nutrients ...
Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production ...
Stocktwits on MSN
SRPT stock rallies after promising early results for RNA therapies targeting rare muscle diseases
Sarepta Therapeutics Inc. (SRPT) on Wednesday released initial results from two investigational programs targeting genetic muscle diseases, demonstrating encouraging safety and biological activity in ...
Eascra Biotech, a nanomedicine startup, has won first place at the TechConnect Bio in Space Innovation Challenge, held during ...
GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets ...
Loomis Sayles, an investment management company, released its fourth-quarter 2025 investor letter for “Small Cap Growth Fund” ...
Researchers have determined how a key protein activates brown fat by expanding blood vessels and nerves in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results